diffuse large B-cell lymphoma - Globe Thesis

Keyword [diffuse large B-cell lymphoma] Result: 181 - 200 \| Page: 10 of 10
181.	Clinical And Pathological Characteristics Of De Novo DLBCLs With Decreased CD20 Cell Surface Expression
182.	Structure Aberration Of MYC Gene And Regulation Of MYC Protein By BCR Signaling In Diffuse Large B-cell Lymphoma
183.	Loss Of IRF8 Inhibits The Growth Of Diffuse Large B-cell Lymphoma
184.	Efficacy Analysis On Rituximab Combined With Chemotherapy In The Treatment Of Diffuse Large B-cell Lymphoma And Bcl-2 Protein Overexpression
185.	Inhibition Of Indoleamine 2, 3-Dioxygenase In CD20+ Diffuse Large B Cell Lymphoma Cell Correlates With Rituximab-mediated Antibody-dependent Cell-mediated Cytotoxicity
186.	The Relationship Between CD10, Bcl-6, VEGF With The Prognosis In The Primary Gastrointestinal Diffuse Large B-cell Lymphoma
187.	Prognostic Significance Of Immunohistochemical Markers In Patients With Diffuse Large B Cell Lymphoma: A Clinical Study On Prognostic Impact Of Rituximab On Immunohistochemical Markers
188.	Expression And Clinical Significance Of MiR-155、miR-15a、miR-16-1 In Patients With Diffuse Large B-cell Lymphoma
189.	Study Of ¹⁸F-FDG PET/CT In The Diagnosis Of Diffuse Large B Cell Lymphoma Chemotherapy Interim And Curative Effect Evaluation
190.	Comparative Study Of R-GEMOX And RICE Regimens As Second-line Treatments For Refractory Or Relapsed DLBCL
191.	Primary Diffuse Large B-cell Lymphoma Of Testis Involving The Skin:one Case Report And Literature Review
192.	The Separation Of Specific Serum Protein Biomarker In Patients With Relapse/refractory Diffuse Large B Cell Lymphoma And The Study Of Its Clinical Value
193.	Doxorubicin And Iron Oxide Nanoparticles Loaded Microbubbles:Dual-mode Imaging And Its Cytotoxic Effect On Lymphoma Cells In Vitro
194.	The Analysis Of Prognosis And Clinical Features In 81 Patients With Diffuse Large B-cell Lymphoma
195.	The Clinical Pathological Research Of Diffuse Large B-cell Lymphoma In Different Age Paragraph
196.	Clinical Analysis Of 18 Cases Of Primary Diffuse Large B Cell Lymphoma Originated From Nasal Cavity And Paranasal Sinus And Nasopharynx
197.	Expression And Clinical Significance Of CMYC,BCL2,BCL6 Protein In Diffuse Large B Cell Lymphoma
198.	An Exploratory Research On Detection Of Diffuse Large B-cell Lymphoma Patients With Volatile Organic Compounds In The Breath
199.	Study Of Rituximab Combined Chemotherapy On Breg And IL-10 Changes In Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
200.	To Investigate The Clinical Characteristics Of Patients With Diffuse Large B-cell Lymphoma And The Factors Related With The Rituximab Effect
<<First <Prev Next> Last>> Jump to